Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (1) , 98-104
- https://doi.org/10.1023/a:1011961006297
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Towards a practical strategy for assessing individual bioequivalence. Food and Drug Administration Individual Bioequivalence Working Group.1996
- Evaluation of Orally Administered Highly Variable Drugs and Drug FormulationsPharmaceutical Research, 1996
- Evaluation of Bioequivalence of Highly Variable Drugs Using Monte Carlo Simulations. I. Estimation of Rate of Absorption for Single and Multiple Dose Trials Using CmaxPharmaceutical Research, 1995
- Comparison of Single and Multiple Dose Pharmacokinetics Using Clinical Bioequivalence Data and Monte Carlo SimulationsPharmaceutical Research, 1994
- Bioequivalence: Performance of Several Measures of Extent of AbsorptionPharmaceutical Research, 1994
- Bioequivalence: Performance of Several Measures of Rate of AbsorptionPharmaceutical Research, 1994
- Bioequivalence revisitedStatistics in Medicine, 1992
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987